about
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsOpioid receptor heteromers in analgesiaPertussis toxin, an inhibitor of G(αi) PCR, inhibits bile acid- and cytokine-induced apoptosis in primary rat hepatocytesAllosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia3D imaging and quantitative analysis of small solubilized membrane proteins and their complexes by transmission electron microscopyHeteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.Elucidation of molecular kinetic schemes from macroscopic traces using system identification.The rhodopsin-transducin complex houses two distinct rhodopsin moleculesTaking two to tango: a role for ghrelin receptor heterodimerization in stress and reward.Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuseLight it up: highly efficient multigene delivery in mammalian cells.Functional selectivity in GPCR heterocomplexes.Functional significance of serotonin receptor dimerization.Biophysical Detection of Diversity and Bias in GPCR Function.Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis.Neurotransmitter receptor complexes: methods for bioanalysis, their potentials and limitations.G-protein-coupled receptor-based drugs rediscovered.New winds in GPCR-based drug discovery.Structural studies of G protein-coupled receptors.The use of electric, magnetic, and electromagnetic field for directed cell migration and adhesion in regenerative medicine.Contribution of heteromerization to G protein-coupled receptor function.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Present and future approaches to screening of G-protein-coupled receptors.Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling.HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans.Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.Family a GPCR heteromers in animal models.Heteromerization of G2A and OGR1 enhances proton sensitivity and proton-induced calcium signals.The Role of Glycans in Bacterial Adhesion to Mucosal Surfaces: How Can Single-Molecule Techniques Advance Our Understanding?
P2860
Q26744729-C3F4658E-C43A-48CC-8F66-860868D86546Q27004306-A2F6D0A2-69E2-4623-AE57-7CA4B2740694Q28482165-7F22D5E2-7A96-45B7-8C56-DCCCA5341455Q34508675-4ED3179C-0970-4227-BA4B-E3ABBA92F8B9Q34522649-530DF18C-62A9-4C62-9158-7B7DF6217D19Q34939624-8AEA5E82-5A42-4E7C-907D-EC688C355420Q36278388-EF79490A-F8D6-4BA5-83CD-1E84BC12DCE5Q36788103-6E230AF1-F030-4479-875D-E6C7AE3DC148Q37132463-1900AD92-B3D6-4940-B9AE-6BF24F918F49Q37680038-64CEB6FD-883E-43AC-AE3C-F83787E6769BQ37946209-63C478F9-B029-4C89-8F26-E8720804121CQ38017279-423BC6FC-4833-4FAC-AB4D-B03D6703B07BQ38118062-98B43015-7053-4D55-A0C4-09DC8FED6A23Q38196401-BC6A4325-3514-420C-9389-71F81288EE97Q38604909-71A978A6-56FC-4A1C-9B22-789DAF5E1DA6Q38613063-D1D25498-ED10-47FB-B68E-A3ADB04E8912Q38683811-4F17AE48-4837-4AB3-AA99-CF6359A0F052Q38877342-11F7144D-D9B7-4F8C-BD7D-9A77D067B538Q38987183-D0D83F60-C636-44CA-9EF4-612501923A62Q38994925-8E95FB6E-532E-40E0-8361-C410E45FF4F7Q39005448-FAB4CCD2-A5F3-41CE-9515-4A04563852A0Q39414464-F6B57CC6-6D7D-43EE-B7C8-2A053FFB4CCAQ39437205-1CD83463-313D-4B76-A1C2-6B42A7A1D0B3Q39518263-88C29C0C-038D-4937-8F3B-94BC50524C65Q40631159-37D512ED-86B1-46DB-8692-8F6359535E1AQ41011634-383A3948-E620-458D-A1EA-0ABAC97F513DQ41651492-6649F900-D878-4377-8183-A7F54FB255AFQ42066825-ADDABA77-16F7-43D6-963D-4E2A3A629478Q42936926-11789B57-8165-4A42-A16B-56A2948B13CBQ51390102-F0173507-E825-42C4-BA82-A45F0F462982Q56888631-3C9A66B6-2C3D-4118-B9AB-98679DCAA2C7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
GPCR oligomers in pharmacology and signaling
@ast
GPCR oligomers in pharmacology and signaling
@en
GPCR oligomers in pharmacology and signaling
@en-gb
GPCR oligomers in pharmacology and signaling
@nl
type
label
GPCR oligomers in pharmacology and signaling
@ast
GPCR oligomers in pharmacology and signaling
@en
GPCR oligomers in pharmacology and signaling
@en-gb
GPCR oligomers in pharmacology and signaling
@nl
prefLabel
GPCR oligomers in pharmacology and signaling
@ast
GPCR oligomers in pharmacology and signaling
@en
GPCR oligomers in pharmacology and signaling
@en-gb
GPCR oligomers in pharmacology and signaling
@nl
P2860
P921
P3181
P356
P1433
P1476
GPCR oligomers in pharmacology and signaling
@en
P2093
Javier González-Maeso
P2860
P2888
P3181
P356
10.1186/1756-6606-4-20
P407
P577
2011-01-01T00:00:00Z
2011-05-27T00:00:00Z
P5875
P6179
1041322727